Literature DB >> 25545486

VITRECTOMY WITH INTERNAL LIMITING MEMBRANE PEELING FOR TRACTIONAL AND NONTRACTIONAL DIABETIC MACULAR EDEMA: Long-term Results of a Comparative Study.

Sophie Bonnin1, Otman Sandali, Sébastien Bonnel, Claire Monin, Mohamed El Sanharawi.   

Abstract

PURPOSE: To compare the long-term outcomes of vitreomacular surgery in eyes with nontractional diabetic macular edema (DME) with those from eyes with tractional DME.
METHODS: Retrospective comparative study from 55 consecutive patients (73 eyes). Twenty eyes were operated on for tractional DME and 53 eyes for nontractional DME unresponsive to laser photocoagulation or triamcinolone intravitreal injections. The best-corrected visual acuity, the central macular thickness, and the surgical complications were analyzed.
RESULTS: The mean follow-up duration was 5.3 ± 2.4 years for the group with traction and 4.4 ± 1.7 years for the group without traction (P = 0.13). At 3 years, the mean logarithm of the minimum angle of resolution best-corrected visual acuity had improved significantly from 0.78 to 0.58 for the group without traction and from 0.75 to 0.45 for the group with traction (P < 0.001). At the final visit, there was no significant difference between the 2 groups in regard to visual or central macular thickness improvement (P = 0.447 and P = 0.742, respectively). The incidence of surgical complications was not significant between the two groups. The preoperative best-corrected visual acuity was the only predictive factor for the final best-corrected visual acuity.
CONCLUSION: The results of vitrectomy were not different in terms of anatomical and visual outcomes and surgical complications between eyes without tractional DME and eyes with tractional DME.

Entities:  

Mesh:

Year:  2015        PMID: 25545486     DOI: 10.1097/IAE.0000000000000433

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  14 in total

Review 1.  Therapeutic Options in Refractory Diabetic Macular Oedema.

Authors:  Sanket U Shah; Raj K Maturi
Journal:  Drugs       Date:  2017-04       Impact factor: 9.546

Review 2.  ILM peeling in nontractional diabetic macular edema: review and metanalysis.

Authors:  M Rinaldi; R dell'Omo; F Morescalchi; F Semeraro; E Gambicorti; F Cacciatore; F Chiosi; C Costagliola
Journal:  Int Ophthalmol       Date:  2017-10-31       Impact factor: 2.031

3.  Role of Combined Therapy of Intravitreal Ranibizumab and Dexamethasone in Refractory Diabetic Macular Edema: a Retrospective Study.

Authors:  Kaushik Sadhukhan; Subhrajyoti Naskar
Journal:  Maedica (Bucur)       Date:  2021-12

Review 4.  Management of diabetic macular edema in Japan: a review and expert opinion.

Authors:  Hiroko Terasaki; Yuichiro Ogura; Shigehiko Kitano; Taiji Sakamoto; Toshinori Murata; Akito Hirakata; Tatsuro Ishibashi
Journal:  Jpn J Ophthalmol       Date:  2017-12-05       Impact factor: 2.447

5.  Vitrectomy for center-involved diabetic macular edema.

Authors:  David J Browning; Chong Lee; Michael W Stewart; Maurice B Landers
Journal:  Clin Ophthalmol       Date:  2016-04-26

Review 6.  Surgical Versus Medical Treatment for Diabetic Macular Edema: A Review.

Authors:  Nicolás Crim; Raúl Velez-Montoya; Virgilio Morales-Canton
Journal:  Med Hypothesis Discov Innov Ophthalmol       Date:  2017

7.  Evaluation of Vitrectomy with Planned Foveal Detachment as Surgical Treatment for Refractory Diabetic Macular Edema with or without Vitreomacular Interface Abnormality.

Authors:  Ahmed M Abdel Hadi
Journal:  J Ophthalmol       Date:  2018-05-07       Impact factor: 1.909

8.  Vitrectomy Combined with Intraoperative Dexamethasone Implant for the Management of Refractory Diabetic Macular Edema.

Authors:  Kyung Tae Kim; Jun Won Jang; Se Woong Kang; Ju Byung Chae; Kyuyeon Cho; Kunho Bae
Journal:  Korean J Ophthalmol       Date:  2019-06

9.  Submacular Injection of Ranibizumab as a New Surgical Treatment for Refractory Diabetic Macular Edema.

Authors:  Samir M El-Baha; Ahmed M Abdel Hadi; Mahmoud A Abouhussein
Journal:  J Ophthalmol       Date:  2019-10-21       Impact factor: 1.909

Review 10.  The Evolving Treatment of Diabetic Retinopathy.

Authors:  Sam E Mansour; David J Browning; Keye Wong; Harry W Flynn; Abdhish R Bhavsar
Journal:  Clin Ophthalmol       Date:  2020-03-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.